asked the Secretary of State for Social Services (1) if he will consult with doctors on whether further opportunities exist to reduce the number of drugs available on the limited list; if he will further consider the effects of such a reduction on patient care; and if he will make a statement;(2) what measures he is taking to foster competition between drug manufacturing companies in the provision of medicines; and if he will make a statement;(3) if he will consider whether the system of licensing and approving new improved drugs could be assisted by encouraging limited trials within the National Health Service; and if he will make a statement.

I shall let my hon. Friend have replies as soon as possible.